Trusted by 100,000+ International Patients
Prostate Cancer Treatment: Italy vs United Kingdom
Cost, Quality & Recovery Compared
$16000
Italy Starting Cost
$8000
United Kingdom Starting Cost
See how these top medical tourism destinations compare for Prostate Cancer Treatment.
| Comparison Factor | Italy | United Kingdom | Winner |
|---|---|---|---|
| Average Cost (in USD) | 16000 - 32000 | 8000 - 27300 | United Kingdom |
| Success Rate (Min and Max) | 88% – 96% | - | Both Equal |
| Advanced Technology | Advanced prostate cancer treatments, including robotic-assisted prostatectomy, IMRT/SBRT radiation therapy, MRI-guided biopsy, PET-CT imaging, hormone therapy, and targeted oncology treatments, are available in leading cancer centres. | - | Both Equal |
| JCI Accredited Hospitals | 20+ | - | Both Equal |
| Visa Process | Schengen Medical Visa / Short-Stay Schengen Visa (Type C) | - | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Rutherford Cancer Centre South Wales , The London Clinic , Woodlands Hospital , St Edmunds Hospital
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Italy and United Kingdom maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Italy hosts internationally accredited cancer centres, including JCI-accredited hospitals, along with nationally recognised institutions that follow strict European oncology care standards.
Oncology centres in Italy report strong outcomes for prostate cancer treatment, supported by experienced urologic oncologists, advanced surgical and radiation technologies, and multidisciplinary cancer care approaches.
Healthcare in Italy is governed by stringent European Union and national regulations, ensuring CE-marked medical devices, approved cancer therapies, standardized clinical protocols, and high levels of patient safety and quality compliance.
Hospitals in the United Kingdom are regulated by the Care Quality Commission, ensuring high standards in oncology care, safety, and clinical governance.
The UK demonstrates excellent prostate cancer outcomes with high survival rates due to early detection, multidisciplinary care, and access to advanced treatment modalities.
Healthcare is governed under strict national systems such as the National Health Service and private healthcare regulators, ensuring adherence to evidence-based oncology protocols and ethical practices.
| Quality Metric | Italy | United Kingdom |
|---|---|---|
Accredited Hospitals | 20+ | 10+ |
Average Success Rate | 90–95% | 92% – 97% |
Post-op / 1-year outcome signal | 88–93% | 90% – 96% |
Top Speciality Hubs | Milan, Rome, Bologna | London, Manchester, Birmingham |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Urologic oncologists, radiation oncologists, and multidisciplinary cancer specialists specialising in prostate cancer surgery, robotic prostatectomy, and precision oncology treatments.
High-volume cancer centres with experienced oncologists trained in advanced prostate cancer management, including surgery, radiation therapy, and systemic treatments.
Highly experienced urologic oncologists, robotic surgeons, and radiation oncologists specialising in prostate cancer surgery, advanced radiotherapy, and systemic treatments including hormone and targeted therapies.
High-volume cancer centres with extensive experience in robotic prostatectomy and complex oncology cases, supported by multidisciplinary tumour boards.
View All Prostate Cancer Treatment Surgeons in United Kingdom →
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Advanced oncology centres equipped with robotic surgical systems, modern radiation therapy units (IMRT, SBRT), PET-CT imaging, molecular diagnostics, and multidisciplinary cancer care units.
Luxury healthcare experience
Advanced oncology hospitals equipped with robotic surgical systems, state-of-the-art radiotherapy units (IMRT, IGRT, VMAT), molecular diagnostics, and comprehensive cancer care units with integrated rehabilitation and survivorship programs.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Prostate Cancer Treatment in both countries.
Advanced oncology ICU and monitoring
Regular PSA monitoring and medication management
Early recovery supported by minimally invasive robotic surgery
Remote oncology follow-up available
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Advanced oncology ICU and monitoring
Regular PSA monitoring and medication management
Early recovery supported by minimally invasive robotic surgery
Remote oncology follow-up available
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Prostate Cancer Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Prostate Cancer Treatment journey.
Reduced through sterile surgical protocols and antibiotics.
Temporary urinary leakage may occur after surgery.
Possible nerve damage affecting erectile function.
Regular PSA monitoring helps detect recurrence early.
Temporary fatigue, nausea, or hormonal side effects.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Men diagnosed with localised or advanced prostate cancer are seeking advanced treatment options such as robotic prostatectomy, radiation therapy, hormone therapy, or targeted oncology care.
Men diagnosed with localised or advanced prostate cancer are seeking advanced treatment options such as robotic prostatectomy, radiation therapy, hormone therapy, or targeted oncology care.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Prostate Cancer Treatment journey.
Assess cancer stage, PSA levels, and overall health before treatment planning.
Consider surgery, radiation therapy, medications, travel, and accommodation costs.
Patients typically stay 2–3 weeks abroad, depending on treatment type.
Provide PSA reports, biopsy results, MRI/CT scans, and oncology consultation records.
Plan long-term PSA monitoring and periodic teleconsultations for recovery tracking.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
